Reletter
Artwork for Pharma Newspress

Pharma Newspress

Pharma Jobs Post

This is our small initiative to share pharmaceutical as well as healthcare related updates with our subscribers

Platform
LinkedIn
PricingOnly free issuesPublishesTwice weekly
Issues35SubscribersRead linkedin.com

Curious about how many subscribers Pharma Newspress has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.

Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.

Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.

Contact Information
How Many Subscribers?
Reletter gives you subscriber numbers, contacts, chart rankings, traffic estimates and more across 1.6m+ newsletters.

Latest Issues

Recent posts by this newsletter. Browse the email archive.

TAKEDA AND BIOLOGICAL E. LIMITED COLLABORATE TO ACCELERATE ACCESS TO DENGUE VACCINE IN ENDEMIC AREAS

* Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per Year by 2030 At the Latest

2 months ago
100
2

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration

* Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selatogrel and Cenerimod, Both With Blockbuster Revenue Potential

2 months ago
71
0

Glenmark partners with Pfizer to launch Abrocitinib in India

 Abrocitinib is the first‐of‐its‐kind oral advanced systemic treatment for adults with moderate‐to‐severe atopic dermatitis, to be made available in India.

2 months ago
259
9

Lupin received approval from the U.S. FDA for its ANDA for Dronedarone Tablets USP

Lupin received approval from the U.S. FDA for its ANDA for Dronedarone Tablets USP to market a generic equivalent of Multaq Tablets of Sanofi-Aventis U.S. LLC.

2 months ago
158
6

Authors

The writers behind this newsletter.

  • Pharma Jobs Post
  • Frequently Asked Questions

    How can I access the email archive for Pharma Newspress?

    You can find recent issues that have been published by Pharma Newspress on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does Pharma Newspress have?

    To see how many people subscribe to Pharma Newspress, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in Pharma Newspress?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch Pharma Newspress as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like Pharma Newspress?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact Pharma Newspress using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters similar to Pharma Newspress?

    Scroll up to where it says Similar Newsletters to see other publications like Pharma Newspress. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact Pharma Newspress?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.